Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHINA RESOLUTE INTEGRITY STUDY Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use --A Prospective, Multi-center, Single Arm, Non-randomized Study

NCT02452736 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT02452736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHINA RESOLUTE INTEGRITY STUDY Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use --A Prospective, Multi-center, Single Arm, Non-randomized Study
Lead sponsor
Medtronic Vascular
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2015
Completion date
December 31, 2015
Enrollment
205 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, cardiovascular diseases, coronary artery disease, ischemic heart disease